Aquestive Therapeutics AQST
NASDAQ AQST
$4.68 -0.07 (-1.58%)
As of: Sep 29, 2026 · 3:59 PM EDT

Aquestive Therapeutics (AQST) Operating Margin (2017 - 2026)

Updated

Aquestive Therapeutics' Operating Margin was -59.51% in Q2 2026, up 54.14 percentage points from -113.65% a year earlier but down 30.40 percentage points from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Operating Margin (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Aquestive Therapeutics' Operating Margin was -97.52% through Jun 30, 2026, up 21.67 percentage points year-over-year; for FY2025, it was -159.50%, down 106.05 percentage points from FY2024.

  • Operating Margin shows a five-year change of -65.95 percentage points (FY2020 to FY2025).
  • In earlier years, Operating Margin was -53.46% in FY2024 (-23.60 pp), -29.86% in FY2023 (+58.37 pp), -88.23% in FY2022 (-20.00 pp) and -68.22% in FY2021 (+25.33 pp).
  • Quarterly Operating Margin has moved between -222.08% (Q1 2025) and 0.27% (Q2 2024) over five years.
  • Compared with a year earlier, Operating Margin was higher in two of the last eight quarters, with an average year-over-year change of -34.74 percentage points.
  • The best year-over-year quarter for Operating Margin over five years was Q1 2026 (a gain of 192.97 percentage points); the worst was Q1 2025 (a drop of 147.76 percentage points).
  • Per Business Quant data, AQST's Operating Margin in the three quarters before Q2 2026 was -29.10% (Q1 2026), -221.58% (Q4 2025) and -89.63% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Aquestive Therapeutics 596.18 Mn 136.72 Mn 9.80 Mn -59.51%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -59.51%
Mar 31, 2026 -29.10%
Dec 31, 2025 -221.58%
Sep 30, 2025 -89.63%
Jun 30, 2025 -113.65%
Mar 31, 2025 -222.08%
Dec 31, 2024 -114.43%
Sep 30, 2024 -61.22%
Jun 30, 2024 0.27%
Mar 31, 2024 -74.31%
Dec 31, 2023 -29.62%
Sep 30, 2023 -18.28%
Jun 30, 2023 -31.79%
Mar 31, 2023 -41.36%
Dec 31, 2022 -100.29%
Sep 30, 2022 -77.23%
Jun 30, 2022 -96.21%
Mar 31, 2022 -79.36%
Dec 31, 2021 -105.33%
Sep 30, 2021 -59.97%
API Access

Aquestive Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=AQST&period=max&api_key=YOUR_API_KEY